Skip to main content
    R

    Royalty Pharma Plc (RPRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $56.57
    -1.21 (-2.09%)

    Market Cap: $34.09B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(27/30)
    Avg Surprise
    +30.84%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.18
    Range$1.15 - $1.22
    6 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$1.14+3.7%
    60d ago$1.16+1.6%
    30d ago$1.180.0%
    7d ago$1.180.0%
    Current$1.18
    Revenue Consensus
    $885M
    Range$879M - $892M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.68
    Range$1.53 - $1.80
    6 analysts
    Revenue Consensus
    $987M
    Range$950M - $1.0B
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.68---
    Sep 26EST
    		-$1.18---
    Jun 26
    Reported Aug 5
    		$1.32$1.27+3.94%Beat+15.8%
    Mar 26
    Reported May 6
    		$1.30$1.18+10.17%Beat+22.6%
    Dec 25
    Reported Feb 11
    		$1.47$1.33+10.53%Beat+27.8%
    Sep 25
    Reported Nov 5
    		$1.17$1.11+5.41%Beat+12.5%
    Jun 25
    Reported Aug 6
    		$1.14$1.03+10.68%Beat+18.7%
    Mar 25
    Reported May 8
    		$1.06$0.95+11.58%Beat+8.2%
    Dec 24
    Reported Feb 11
    		$1.15$1.05+9.52%Beat-24.3%
    Sep 24
    Reported Nov 6
    		$1.04$0.93+11.83%Beat+31.6%
    Jun 24
    Reported Aug 8
    		$0.96$0.97-1.03%Miss+14.3%
    Mar 24
    Reported May 9
    		$0.98$0.98+0.00%Beat-38.8%
    Dec 23
    Reported Feb 15
    		$1.52$1.00+52.00%Beat-2.6%
    Sep 23
    Reported Nov 8
    		$0.79$0.77+2.60%Beat+8.2%
    Jun 23
    Reported Aug 8
    		$0.84$0.81+3.70%Beat+6.3%
    Mar 23
    Reported May 9
    		$1.60$1.27+25.98%Beat+166.7%
    Dec 22
    Reported Feb 15
    		$1.56$1.46+6.85%Beat+95.0%
    Sep 22
    Reported Nov 8
    		$0.73$0.71+2.82%Beat+0.0%
    Jun 22
    Reported Aug 4
    		$0.79$0.78+1.28%Beat+11.3%
    Mar 22
    Reported May 5
    		$0.60$0.72-16.67%Miss-10.4%
    Dec 21
    Reported Feb 15
    		$0.80$0.78+2.56%Beat+14.3%
    Sep 21
    Reported Nov 10
    		$0.73$0.70+4.29%Beat+12.3%
    Jun 21
    Reported Aug 11
    		$0.71$0.71+0.00%Beat+16.4%
    Mar 21
    Reported May 11
    		$0.67$0.65+3.08%Beat-83.0%
    Dec 20
    Reported Feb 17
    		$0.70$0.70+0.00%Beat+1500.0%
    Sep 20
    Reported Nov 10
    		$0.65$0.59+10.17%Beat+912.5%
    Jun 20
    Reported Aug 12
    		$0.61$0.60+1.67%Beat+377.3%
    Mar 20
    Reported Jun 17
    		$3.94$0.52+657.69%Beat+2562.5%
    Sep 17
    Reported Sep 30
    		$-0.05N/A+82.14%Beat-
    Jun 17
    Reported Jun 30
    		$-0.08N/A+63.64%Beat-
    Mar 17
    Reported Mar 31
    		$-0.22$-0.14-57.14%Miss-
    Dec 16
    Reported Dec 31
    		$-0.16$-0.17+5.88%Beat-

    Dividends

    Dividend Metrics

    Forward Yield1.66%
    Forward Annual Dividend$0.94
    Payout Ratio30.50%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+5.01%
    RPRX dividend history and ex-dividend datesRun RPRX in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio10.75EV/EBITDA20.32x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin32.00%Operating Margin19.80%
    ROE14.00%ROIC8.20%
    Financial Health
    Debt/Equity1.31xInterest Coverage4.54x
    Current Ratio2.80xQuick Ratio2.80x
    Trading Statistics
    Beta0.41Avg Volume2.97M
    52-Week High$64.3852-Week Low$35.23

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$57.05
    SMA 20$57.70
    SMA 50$59.10
    SMA 200$51.47
    EMA 10$57.15
    EMA 20$57.74
    EMA 50$58.18
    EMA 200$52.24

    MACD

    Line: -0.73Signal: -0.69Hist: -0.04

    ADX

    ADX: 33.0+DI: 12.3-DI: 23.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down88.0
    PSAR$55.19

    Bollinger Bands

    Upper Band$59.39
    Lower Band$56.01
    %B Position585%(Upper)
    Band Width0.17

    RSI (14-Day)

    Neutral
    40.2

    Momentum Oscillators

    Stoch %K50.9
    Stoch %D43.6
    Williams %R-61.5
    ROC (10d)-2.8%
    Momentum-1.65
    CCI (20d)-66.0
    MFI (14d)42.0

    Volatility Measures

    ATR (14d)$1.26(2.2%)
    StdDev (20d)0.84
    Hist Vol15.1%(Low)

    Volume Flow

    VWAP$56.99
    OBV317.3M
    AD Line-1.5B
    CMF (20d)-0.007

    Volume Metrics

    Avg Vol (20d)3.0M
    Vol Ratio1.2x
    VWMA (20d)$57.68

    Pivot Points

    R3$59.25
    R2$58.59
    R1$58.18
    Pivot Point$57.52
    S1$57.11
    S2$56.45
    S3$56.04

    Advanced Oscillators

    TSI-19.71
    Ultimate Osc54.0
    KST-46.36

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$674.14M$630.58M$621.99M$609.29M$578.66M$568.25M$593.64M$564.69M$537.27M$567.98M$596.07M$536.31M
    Cost of Revenue$0$0$1.20M$0$0$0$164.04M$0$0$0$76.51M$0
    Gross Profit$674.14M$630.58M$621.99M$609.29M$578.66M$568.25M$593.64M$564.69M$537.27M$567.98M$596.07M$536.31M
    Operating Expenses$541.02M$67.54M$233.61M$182.13M$368.87M$34.06M$232.13M$-170,384,000$267.64M$641.75M$-16,828,000$384.87M
    R&D$97.85M$39.79M$50.50M$50.50M$300.50M$50.50M$500,000$500,000$500,000$500,000$500,000$50.50M
    SG&A$161.89M$159.49M$164.27M$118.73M$179.77M$110.70M$67.59M$56.72M$54.71M$57.65M$59.19M$57.23M
    Operating Income$133.12M$563.04M$388.38M$427.16M$209.80M$534.18M$361.51M$735.07M$269.63M$-73,774,000$612.90M$151.44M
    Interest Income$9.20M$27.99M$11.08M$22.85M$11.02M$17.73M$40.69M$27.91M$15.08M$-6,732,000$6.77M$18.21M
    Interest Expense$93.62M$93.72M$94.17M$79.56M$68.67M$65.26M$65.76M$66.51M$49.01M$44.23M$47.26M$46.03M
    Income Before Tax$81.49M$468.26M$355.91M$444.21M$92.64M$434.43M$334.35M$806.36M$194.38M$-4,273,000$717.59M$122.08M
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$81.49M$468.26M$355.91M$444.21M$92.64M$434.43M$334.35M$806.36M$194.38M$-4,273,000$717.59M$122.08M
    EBITDA$165.90M$533.99M$439.01M$500.92M$150.28M$481.96M$359.43M$844.95M$228.31M$46.69M$758.07M$149.90M
    EBIT$165.90M$533.99M$439.01M$500.92M$150.28M$481.96M$359.43M$844.95M$228.31M$46.69M$758.07M$149.90M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RPRX

    News

    Royalty Pharma Announces Fourth-Quarter 2026 Dividend of $0.235 Per Class A Ordinary Share

    Royalty Pharma plc has declared a fourth-quarter 2026 dividend of $0.235 per Class A ordinary share, payable on December 10, 2026, to shareholders of record as of November 13, 2026. The company, established in 1996...

    Quiver Quantitative•10/16/26•Neutral

    Shareholders are set to get 23.5 cents per share from Royalty Pharma on Dec. 10.

    Royalty Pharma (Nasdaq: RPRX) has announced a fourth-quarter 2026 dividend of $0.235 per Class A ordinary share. This dividend will be paid on December 10, 2026, to shareholders of record as of November 13...

    Stock Titan•10/16/26•Somewhat-Bullish

    Global femtech market to reach $255.5B by 2035, driven by AI, telehealth, and personalized women's healthcare.

    The global femtech market is projected to reach $255.5 billion by 2035, growing from $66.2 billion in 2025 at a CAGR of 14.9%. This significant growth is attributed to the integration of digital technologies like AI...

    Pluang•10/15/26•Bullish

    Form 4 Royalty Pharma Plc For: 12 October By Investing.com

    The article reports on a Form 4 filing for Royalty Pharma Plc (RPRX) dated October 12, published by Investing.com. It mentions that the stock symbol RPRX is down 2.09% and provides a general financial markets context....

    Investing.com UK•10/12/26•Neutral

    Royalty Pharma EVP Marshall Urist sells $235,594 in shares

    Marshall Urist, Executive Vice President of Research & Investments at Royalty Pharma plc, sold 4,126 Class A Ordinary Shares totaling $235,594 on October 5, 2026...

    Investing.com•10/12/26•Neutral

    RPRX Valuation and Fair Value

    P/E
    10.8x
    Forward P/E
    29.4x
    EV/EBITDA
    20.3x
    PEG
    1.3x
    P/B
    3.7x
    See GNG's fair value

    RPRX Profitability: Margins, ROIC and FCF

    Gross margin
    100.0%
    Operating margin
    19.8%
    Net margin
    32.0%
    ROIC
    8.2%
    ROE
    14.0%
    FCF margin
    117.3%

    RPRX Competitors

    CompanyTicker
    Biogen IncBIIB
    ResMed IncRMD
    Centene CorpCNC
    Mettler-Toledo International IncMTD
    BeiGene, Ltd.ONC
    DexCom IncDXCM
    IDEXX Laboratories IncIDXX
    GE HealthCare Technologies Inc.GEHC

    Sector: Healthcare

    RPRX Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    2
    Buy
    5
    Hold
    1
    Sell
    0
    Strong Sell
    0

    RPRX Bull Case vs Bear Case

    Bull case

    • RPRX converts 117.3% of revenue into free cash flow.
    • RPRX has a 32.0% net profit margin.
    • RPRX beat EPS estimates in 100.0% of its last 8 reported quarters.

    RPRX Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    9.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.18
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    RPRX Dividend

    Forward yield
    1.7%
    Payout ratio
    30.5%
    3Y DPS growth
    5.0%
    Pay months
    Mar, Jun, Sep, Dec
    RPRX dividend history

    Frequently Asked Questions About RPRX

    What is RPRX's current dividend yield?

    Royalty Pharma Plc (RPRX) has a forward dividend yield of 1.66%.

    Does RPRX pay dividends?

    Yes, Royalty Pharma Plc pays dividends with a forward dividend yield of 1.66%.

    What is RPRX's P/E ratio?

    Royalty Pharma Plc has a price-to-earnings (P/E) ratio of 10.75.

    What is RPRX's market cap?

    Royalty Pharma Plc (RPRX) has a market capitalization of $34.09B with a current stock price of $56.57.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In